Mel Sorensen
-
Stock of Local Biopharmaceutical Company Takes a Dive After Disappointing Trial for Its Lead Therapy
Malvern-based Galera Therapeutics’ stock fell by more than 70 percent after the biopharmaceutical firm announced that its cancer drug candidate…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
